Coeptis Therapeutics, Inc. (COEP)
NASDAQ: COEP · IEX Real-Time Price · USD
0.286
-0.012 (-3.99%)
At close: Jul 19, 2024, 4:00 PM
0.285
-0.001 (-0.31%)
Pre-market: Jul 22, 2024, 8:27 AM EDT
Coeptis Therapeutics Employees
As of December 31, 2023, Coeptis Therapeutics had 7 total employees, including 5 full-time and 2 part-time employees. The number of employees increased by 2 or 40.00% compared to the previous year.
Employees
7
Change (1Y)
2
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$2,330,013
Market Cap
10.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 2 | 40.00% |
| Dec 31, 2022 | 5 | 0 | - |
| Dec 31, 2021 | 5 | 0 | - |
| Dec 31, 2020 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Tonix Pharmaceuticals Holding | 103 |
| Mustang Bio | 80 |
| Senti Biosciences | 48 |
| Dominari Holdings | 28 |
| Plus Therapeutics | 20 |
| ABVC BioPharma | 19 |
| Traws Pharma | 18 |
| Moleculin Biotech | 18 |
COEP News
- 4 weeks ago - Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering - PRNewsWire
- 7 weeks ago - Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting - PRNewsWire
- 2 months ago - Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024 - PRNewsWire
- 2 months ago - Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting - PRNewsWire
- 3 months ago - Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research Award - PRNewsWire
- 5 months ago - Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK - PRNewsWire
- 5 months ago - Coeptis Therapeutics to Pursue Phase 2 Program Using Proprietary First-in-Class Allogeneic NK Cell Therapy for the Treatment of Viral Infections - PRNewsWire
- 7 months ago - Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024 - PRNewsWire